Markus H. Berger
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer.
Journal: Cancer discovery
Published: May 14, 2025
The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence-Based Approach.
Journal: Allergy
Published: April 16, 2025
In Vitro and In Vivo Stability Assessment of the Novel, Macrocyclic Gadolinium-Based Contrast Agent Gadoquatrane.
Journal: Investigative radiology
Published: January 31, 2025
Mould allergen Alt a 1 spiked with the micronutrient retinoic acid reduces Th2 response and ameliorates Alternaria allergy in BALB/c mice.
Journal: Allergy
Published: December 14, 2023
Nutritional Provision of Iron Complexes by the Major Allergen Alt a 1 to Human Immune Cells Decreases Its Presentation.
Journal: International journal of molecular sciences
Published: May 31, 2023
A Novel NAMPT Inhibitor-Based Antibody-Drug Conjugate Payload Class for Cancer Therapy.
Journal: Bioconjugate chemistry
Published: June 06, 2022
Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities.
Journal: Clinical and translational allergy
Published: May 16, 2022
Last Updated: 09/26/2026